People's Insurance Co (Group) of China (1339) AI Stock Analysis

• Market Cap: HK$392.78B
• Dividend Yield: 2.06%
• Average Volume (3M): 57.93M
• Price to Earnings (P/E): 5.8
• Beta (1Y): 0.93
• Revenue Growth: 4.62%
• EPS Growth: 81.63%
• Country: HK
• Employees: 175,121
• Sector: Financial
• Sector Strength: 79
• Industry: Insurance - Property & Casualty
• EPS (TTM): 0.32
• Shares Outstanding: 8,726,234,000
• 10 Day Avg. Volume: 68,380,008
• 30 Day Avg. Volume: 57,929,775
• PEG Ratio: 0.23
• Price to Book (P/B): 0.46
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 1.55
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$5.10
• Price Target Upside: -16.35% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 78 Outperform
• Price Target: HK$7.00 ▲(14.75%Upside)

People's Insurance Co (Group) of China is supported by strong financial performance and attractive valuation. While the stock shows bullish momentum, technical indicators suggest it might be overbought, posing a potential risk for short-term correction. The absence of earnings call and corporate events data does not affect the solid underlying fundamentals.

People's Insurance Co (Group) of China Business Overview & Revenue Model

Company Description

The People's Insurance Company (Group) of China Limited, an investment holding company, engages in the insurance business in the People's Republic of China. It operates through Non-Life Insurance, Life Insurance, Health Insurance, Asset Management, and Others segments. The company offers property and casualty insurance products, including motor vehicle, commercial property, liability, credit, accidental injury and health, cargo, agricultural, and other insurance products. It also provides life insurance products comprising general life and health insurance, participating life insurance, universal life insurance, and accident insurance; and health insurance products, such as medical, illness, nursing care, accidental injury, disability losses, and participating endowment insurance products. In addition, the company engages in asset management, insurance agent, and reinsurance business, as well as offers integrated financial products and services. The People's Insurance Company (Group) of China Limited was founded in 1949 and is based in Beijing, the People's Republic of China.

How the Company Makes Money

PICC Group generates revenue through the underwriting and selling of various insurance products, which form the core of its business model. The primary revenue streams for the company include premiums earned from property and casualty insurance, life insurance, and health insurance policies. Additionally, the company earns income from investment activities, leveraging the premiums collected to invest in a diversified portfolio of assets, including bonds, stocks, and other financial instruments. Significant partnerships with domestic and international reinsurers also play a role in managing risk and stabilizing earnings. Factors such as regulatory changes, economic conditions, and demographic trends in China significantly influence the company's earnings potential.

People's Insurance Co (Group) of China Financial Statement Overview

Summary

People's Insurance Co (Group) of China demonstrates strong financial health with consistent revenue and profit growth. The company effectively manages its capital structure, reducing leverage while maintaining high liquidity. The robust cash flow supports ongoing operations and investments, though attention to liability management is advised to mitigate potential risks.

Income Statement

The income statement demonstrates strong profitability with an increasing net profit margin from 4.5% in 2023 to 7.8% in 2024. The revenue growth rate is also impressive at 9.4% in 2024, indicating robust growth. EBIT and EBITDA margins have improved significantly, reflecting efficient cost management and operational performance.

Balance Sheet

The balance sheet is solid with a declining debt-to-equity ratio, reaching 0.19 in 2024, which signifies reduced financial leverage. The equity ratio is stable, and ROE has improved to 15.9% in 2024, showcasing effective use of shareholders' equity. However, the high total liabilities remain a potential risk.

Cash Flow

The cash flow statement shows a healthy operating cash flow, with a strong free cash flow growth of 24.8% in 2024. The operating cash flow to net income ratio is robust at 2.05, indicating strong cash generation relative to accounting earnings. However, fluctuations in investing cash flow could pose challenges.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	549.16B	501.76B	614.64B	592.01B	579.77B
Gross Profit	549.16B	501.76B	614.64B	592.01B	579.77B
EBITDA	77.48B	42.98B	42.86B	45.90B	41.75B
Net Income	42.87B	22.77B	34.43B	30.37B	28.23B
Balance Sheet
Total Assets	1.77T	1.56T	1.51T	1.38T	1.26T
Cash, Cash Equivalents and Short-Term Investments	664.26B	21.87B	21.36B	21.79B	23.13B
Total Debt	52.60B	40.26B	46.20B	47.43B	60.34B
Total Liabilities	1.40T	1.23T	1.21T	1.08T	982.51B
Stockholders Equity	268.73B	242.35B	221.77B	219.26B	202.48B
Cash Flow
Free Cash Flow	83.59B	66.98B	65.08B	110.35B	59.83B
Operating Cash Flow	87.99B	70.55B	71.65B	72.73B	31.87B
Investing Cash Flow	-77.60B	-70.93B	-73.28B	-81.56B	-51.37B
Financing Cash Flow	4.86B	-11.48B	8.56B	-35.86B	21.11B

People's Insurance Co (Group) of China Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 6.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1339, the sentiment is Positive. The current price of 6.1 is above the 20-day moving average (MA) of 5.57, above the 50-day MA of 5.13, and above the 200-day MA of 4.15, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 71.58 is Negative, neither overbought nor oversold. The STOCH value of 89.32 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1339.

People's Insurance Co (Group) of China Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2328	79 Outperform	$344.32B	9.87	13.15%	5.72%	3.52%	26.44%
1339	78 Outperform	HK$392.78B	5.80	17.85%	2.06%	4.62%	81.63%
1336	75 Outperform	HK$184.39B	4.88	26.08%	2.09%	-43.77%	―
0966	72 Outperform	$55.20B	7.43	9.88%	1.88%	17.76%	38.31%
6099	71 Outperform	€162.61B	11.77	8.73%	2.69%	-2.52%	17.25%
2601	70 Outperform	$363.55B	5.89	16.47%	4.17%	11.99%	54.60%
Sector *	60 Neutral	C$14.55B	5.45	20.17%	6.16%	26.88%	-38.18%

People's Insurance Co (Group) of China Corporate Events

People’s Insurance Co. Announces 2024 AGM with Key Resolutions

The People’s Insurance Company (Group) of China Limited has announced its 2024 Annual General Meeting, scheduled for June 27, 2025, in Beijing. The meeting will address various resolutions, including the approval of financial accounts, profit distribution, and capital planning for the upcoming years. The AGM will also consider amendments to the company’s Articles of Association and procedural rules, reflecting strategic adjustments aimed at enhancing governance and operational efficiency.

The most recent analyst rating on (HK:1339) stock is a Hold with a HK$4.10 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.

People’s Insurance Co of China Updates Final Dividend Details

The People’s Insurance Company (Group) of China Limited announced an update regarding its final cash dividend for the financial year ending December 31, 2024. The dividend is set at RMB 0.117 per share, with the payment date scheduled for August 8, 2025. The update includes details on shareholder approval, Hong Kong share register information, and withholding tax arrangements. This announcement reflects the company’s commitment to returning value to its shareholders and may impact its market positioning and investor relations.

The most recent analyst rating on (HK:1339) stock is a Hold with a HK$4.10 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.

People’s Insurance Co (Group) of China Announces EGM Results

The People’s Insurance Company (Group) of China Limited announced the successful passing of resolutions at its 2025 first extraordinary general meeting held on April 29, 2025. Key resolutions included the approval of the remuneration scheme for directors and supervisors for 2023 and the election of new directors to the board. The meeting complied with relevant legal and regulatory requirements, and no shareholders were required to abstain from voting.

People’s Insurance Co. Proposes Amendments to Articles of Association

The People’s Insurance Company (Group) of China Limited has proposed amendments to its Articles of Association, which were approved by its board of directors. These amendments are subject to approval at the company’s general meeting and by the National Financial Regulatory Administration. The changes aim to align the company’s governance with relevant laws and regulations, potentially impacting its operational framework and stakeholder relations.

People’s Insurance Co of China Reports Strong Q1 2025 Financial Growth

The People’s Insurance Company (Group) of China Limited reported significant financial growth in its first quarterly report of 2025, with a 12.8% increase in total operating income and a 43.4% rise in net profit attributable to the owners compared to the previous year. This growth reflects a strong operational performance and improved market positioning, benefiting stakeholders and enhancing the company’s financial stability.

People’s Insurance Co. Schedules 2025 Q1 Results Announcement

The People’s Insurance Company (Group) of China Limited has announced the scheduling of its 2025 First Quarter Results Announcement. This event will be conducted through a text interaction session on April 30, 2025, allowing investors to engage and have their questions addressed. This initiative reflects the company’s commitment to transparency and active communication with its stakeholders, potentially enhancing its market position and investor relations.

People’s Insurance Co. Announces Board Meeting for Q1 Results

The People’s Insurance Company (Group) of China Limited has announced a board meeting scheduled for April 29, 2025, to review and approve the unaudited financial results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder interests.

People’s Insurance Co. Projects Significant Profit Growth in Q1 2025

The People’s Insurance Company (Group) of China Limited announced an estimated net profit increase for the first quarter of 2025, projecting a rise of 30% to 50% compared to the previous year. This growth is attributed to strategic reforms and innovations, improved underwriting performance, and significant investment returns, reflecting the company’s alignment with national strategies and its focus on high-quality development.

PICC Announces 2025 First Extraordinary General Meeting

The People’s Insurance Company (Group) of China Limited has announced the convening of its 2025 first extraordinary general meeting (EGM) to be held on April 29, 2025. The meeting will address several key resolutions, including the approval of the remuneration scheme for directors and supervisors for 2023, and the election of new non-executive and independent non-executive directors to the board. This meeting is significant for stakeholders as it will influence the company’s governance and strategic direction, potentially impacting its market positioning and operational effectiveness.